Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?

Vivian M. Rumjanek, Raphael S. Vidal, Raquel C. Maia

Open source

DOI: 10.1042/bsr20130067
Published: 2013-11-25
Container: Bioscience Reports
Publisher: Portland Press Ltd.
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1042/bsr20130067,
  title = {Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?},
  author = {Vivian M. Rumjanek and Raphael S. Vidal and Raquel C. Maia},
  year = {2013},
  journal = {Bioscience Reports},
  doi = {10.1042/bsr20130067},
  url = {https://doi.org/10.1042/bsr20130067}
}

RIS

TY  - JOUR
TI  - Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?
AU  - Vivian M. Rumjanek
AU  - Raphael S. Vidal
AU  - Raquel C. Maia
PY  - 2013
JO  - Bioscience Reports
DO  - 10.1042/bsr20130067
UR  - https://doi.org/10.1042/bsr20130067
ER  -

APA

Rumjanek, V. M., Vidal, R. S., & Maia, R. C. (2013). Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?. Bioscience Reports. https://doi.org/10.1042/bsr20130067

Source records

crossref · retrieved 2026-11-04T11:40:57.414Z